As per MRFR analysis, the South Korea Heart Valves Market Size was estimated at 185.13 (USD Million) in 2023. The South Korea Heart Valves Market Industry is expected to grow from 192.8(USD Million) in 2024 to 384.5 (USD Million) by 2035. The South Korea Heart Valves Market CAGR (growth rate) is expected to be around 6.476% during the forecast period (2025 - 2035).
Key South Korea Heart Valves Market Trends Highlighted
The South Korea Heart Valves Market is witnessing several significant trends driven by various factors. One of the key market drivers is the growing prevalence of cardiovascular diseases among the aging population. With a rapidly increasing elderly demographic, the demand for heart valve procedures is on the rise, leading to more advanced treatment options.
Additionally, advancements in medical technology have enabled the development of minimally invasive heart valve replacement procedures, which are becoming increasingly popular in South Korea. This shift not only improves patient recovery times but also enhances overall clinical outcomes. Opportunities to be explored in this market include the potential for expansion in telemedicine and remote patient monitoring, particularly following the COVID-19 pandemic.These digital solutions could be instrumental in the provision of follow-up care for heart valve patients as healthcare systems strive to enhance patient engagement and comply with safety protocols.
Additionally, local manufacturers are investing in research and development to develop innovative heart valve products that are specifically designed to meet the requirements of South Korean patients. This presents a promising opportunity for market expansion. In recent years, there has been a growing emphasis on bioprosthetic heart valves due to their decreased reliance on anticoagulation and their long-term efficacy. The development of new products is also being facilitated by South Korea's emphasis on the promotion of partnerships between research institutions and medical device companies and the improvement of healthcare infrastructure.
In general, the South Korea Heart Valves Market is continuing to be influenced by a supportive regulatory environment, a growing patient population, and advanced technology, which underscores the importance of stakeholders considering dynamic trends.
 
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
South Korea Heart Valves Market Drivers
Rising Prevalence of Cardiovascular Diseases
The South Korea Heart Valves Market is experiencing significant growth driven by the increasing prevalence of cardiovascular diseases. According to the Ministry of Health and Welfare in South Korea, cardiovascular disease is the leading cause of death, accounting for approximately 30% of all deaths in the country. This alarming statistic underlines a growing patient population that is likely to require heart valve interventions over the coming years.Major establishments such as the Korean Society of Interventional Cardiology are actively researching and developing innovative treatment options, which further enhance market demand.
Additionally, the Korean Institute of Cardiovascular Disease documented an increase in heart-related ailments by over 15% in recent years, indicating an urgent need for effective heart valve solutions. This situation presents a robust opportunity for the South Korea Heart Valves Market Industry as healthcare providers seek advanced technologies to manage and treat rising cardiovascular issues.
Technological Advancements in Heart Valve Devices
The South Korea Heart Valves Market is propelled by rapid technological advancements in heart valve devices. Recent innovations, such as transcatheter aortic valve replacement (TAVR) systems and minimally invasive surgical techniques, have gained traction in South Korea. According to the South Korean Ministry of Health and Welfare, TAVR cases have surged by about 25% annually, showcasing the growing acceptance of these advanced procedures.
Renowned organizations, including Seoul National University Hospital, are pioneering Research and Development (R&D) efforts focused on enhancing the safety and efficacy of these devices.These advancements not only broaden the treatment options available to patients but also improve recovery times, creating a positive outlook for the South Korea Heart Valves Market Industry.
Aging Population in South Korea
The South Korea Heart Valves Market is significantly influenced by the aging population, which is leading to a higher incidence of heart valve-related disorders. The Korea Statistical Information Service predicts that by 2025, nearly 20% of South Korea's population will be 65 years or older. This demographic shift results in a growing incidence of age-related cardiovascular diseases, as older individuals are more susceptible to complications that necessitate heart valve repairs or replacements.
Institutions like the Korean National Health Insurance Service are observing an upward trend in the number of heart surgeries being performed, which is creating a substantial demand for heart valve solutions. Such demographic changes will provide continued growth opportunities for the South Korea Heart Valves Market Industry.
South Korea Heart Valves Market Segment Insights
Heart Valves Market Type Insights
The South Korea Heart Valves Market has been experiencing notable growth, driven by the need for advanced cardiac care and improved patient outcomes. The market can be categorized primarily into Mechanical Valves, Bioprosthetic Valves, and Transcatheter Valves, each holding its unique significance in the overall landscape. Mechanical Valves are known for their durability and longevity, making them a favored choice for patients who require long-term intervention. Their ability to withstand high pressure and continuous use is a critical factor in their prevalence, particularly among younger patients who may require years of functionality.
Bioprosthetic Valves, on the other hand, offer the advantage of reduced thrombogenicity, making them an appealing option for older patients or those who may face an increased risk of blood clots. Their compatibility with the human body and the lower need for anticoagulation therapy underline their growing adoption in South Korea. As the population ages and the prevalence of heart disease rises, the demand for these valves will likely continue to escalate, reflecting changing patient profiles and medical technologies. Transcatheter Valves are gaining traction as a minimally invasive alternative, revolutionizing treatment for patients who are at higher surgical risks.
By allowing for valve replacement through a catheter, these devices not only improve recovery times but also expand treatment options for those previously considered inoperable. The rise of minimally invasive procedures aligns well with the increasing focus on patient-centered care viewed in the South Korean healthcare industry, illustrating the shift toward innovative procedural methodologies. The innovations and advancements within each type segment not only enhance surgical outcomes but also contribute to the overall South Korea Heart Valves Market revenue.
As technological developments continue, each valve type is expected to evolve, addressing patient needs and improving health outcomes across diverse demographics. Overall, the dynamics of the market segmentation within the South Korea Heart Valves Market is indicative of a broader trend towards personalized and efficient medical solutions in cardiovascular treatment.
 
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Heart Valves Market Application Insights
The Application segment of the South Korea Heart Valves Market is characterized by its focus on essential procedures such as Aortic Valve Repair, Mitral Valve Repair, and Tricuspid Valve Repair, addressing significant cardiovascular issues faced in the region. Aortic Valve Repair has gained prominence due to the increasing prevalence of aortic stenosis among the aging population, often leading to the need for interventions to enhance patient outcomes. Mitral Valve Repair, another key area, plays a crucial role as mitral valve regurgitation affects a significant portion of the population, necessitating efficient repair techniques to improve heart function.
Tricuspid Valve Repair is also vital, as it addresses both primary and secondary valvular diseases that can lead to right heart failure, emphasizing the importance of early detection and surgical intervention. The growing focus on minimally invasive procedures and advancements in surgical techniques are driving innovations across these applications, while the increasing health awareness and clinical research efforts within South Korea further support the market's expansion in this segment. Overall, these applications are fundamental in shaping treatment pathways and improving the quality of life for patients with heart valve disorders in the country.
Heart Valves Market End Use Insights
The South Korea Heart Valves Market exhibits significant segmentation in the End Use category, primarily encompassing Hospitals, Ambulatory Surgical Centers, and Cardiac Clinics. Hospitals are critical players in this segment due to their comprehensive facilities and specialized staff, which cater to complex heart valve procedures and surgeries. With the increasing prevalence of cardiovascular diseases, these medical institutions provide essential care, making them a dominant force in the market. Ambulatory Surgical Centers are gaining traction as they offer less invasive procedures with shorter recovery times, appealing to a growing population of patients seeking efficient treatment options.
This trend is bolstered by advancements in minimally invasive surgical techniques, which enhance patient outcomes. Meanwhile, Cardiac Clinics focus on diagnosis and treatment, providing specialized care that is vital for heart valve management. These clinics are increasingly essential as they offer targeted treatments and follow-up care, addressing the specific needs of patients with heart conditions. Overall, the segmentation within the South Korea Heart Valves Market reflects a response to the evolving healthcare landscape, prioritizing efficient and specialized care to improve patient quality of life.
Heart Valves Market Material Insights
The South Korea Heart Valves Market focuses on the Material segment, which plays a vital role in the effectiveness and longevity of heart valve replacements. This segment is primarily composed of Biological Tissue, Synthetic Polymer, and Metallic Alloys. Biological Tissue valves are gaining popularity due to their natural compatibility with the human body, offering an appealing option for patients seeking reduced long-term complications. On the other hand, Synthetic Polymers are increasingly significant as they provide durability and resistance to wear, catering to an active patient demographic.Metallic Alloys remain a traditional choice due to their strength and reliability, making them essential in various surgical applications.
The diversity within the Material segment reflects ongoing innovation and investment in Research and Development, with a focus on improving patient outcomes and reducing recovery time. The South Korea Heart Valves Market data indicates that advancements in these materials are driven by the nation’s emphasis on enhancing healthcare technology and responding to a growing elderly population that demands effective cardiac solutions.This segment is vital for addressing both current needs and future trends in cardiac care within South Korea.
South Korea Heart Valves Market Key Players and Competitive Insights
The South Korea Heart Valves Market is characterized by a dynamic competitive landscape driven by the increasing prevalence of cardiovascular diseases and advancements in medical technology. This market features a mix of established players and emerging companies, all vying to capture market share through innovative products and strategic partnerships. The competitive insights reflect a growing trend towards minimally invasive procedures, which is shaping the development of heart valve technologies.
Additionally, collaboration with healthcare providers and ongoing clinical trials further influence market strategies, enabling companies to enhance their offerings and improve patient outcomes. The unique regulatory environment in South Korea additionally poses both challenges and opportunities for the players in this sector, necessitating tailored approaches to product development and marketing.Neovasc has established a notable presence in the South Korean Heart Valves Market, particularly through its innovative approach to providing solutions for patients suffering from heart conditions. The company's focus on developing advanced transcatheter technologies has positioned it as a key player in this market, where demand for less invasive treatment methods is on the rise.
Neovasc's strengths include its commitment to research and development, which has led to the introduction of sophisticated heart valve technologies aimed at improving patient outcomes. This focus has garnered attention within the South Korean healthcare community, allowing Neovasc to build strong partnerships with local hospitals and medical professionals. The company’s agility in responding to market dynamics and emphasis on regulatory compliance further solidifies its competitive edge in South Korea.
St. Jude Medical, now part of an acquired entity, has a significant footprint in the South Korea Heart Valves Market, renowned for its diverse range of cardiac devices, including advanced heart valves and related therapies. The company's key products are designed to cater to a variety of heart valve disorders, reinforcing its position in both the surgical and interventional spaces. St. Jude Medical’s strengths lie in its robust portfolio, which addresses a broad spectrum of cardiac issues, alongside its established reputation for reliability and innovation.
The company has actively pursued mergers and acquisitions, enhancing its market capabilities and expanding its technological prowess in heart valve solutions specific to the South Korean market. Its strategic partnerships with local healthcare providers and research institutions further facilitate access to cutting-edge innovations, ensuring that it remains a prominent player in the competitive landscape of heart valves within South Korea.
Key Companies in the South Korea Heart Valves Market Include:
South Korea Heart Valves Market Industry Developments
The South Korea Heart Valves Market is witnessing significant developments, particularly with companies such as Edwards Lifesciences, Medtronic, and Abbott Laboratories actively promoting technological advancements in heart valve therapies. In September 2023, Edwards Lifesciences launched a new transcatheter heart valve device, enhancing treatment options for patients with severe aortic stenosis.
Additionally, Medtronic announced an expansion plan in August 2023 to increase production capacity to meet the rising demand for heart valve implants in the region. Recently, in July 2023, Sino Medical Sciences Technology secured regulatory approval for its innovative heart valve technology, indicating a robust growth trajectory in the South Korean market.
Mergers and acquisitions remain a focal point, as in June 2023, Boston Scientific acquired a small medical device company, enhancing its heart valve product portfolio. The market has shown an upward valuation trend, attributed to an aging population and increasing incidences of cardiovascular diseases in South Korea, paving the way for more innovative solutions and strategic partnerships among key players like Neovasc and LivaNova in addressing these healthcare challenges.
South Korea Heart Valves Market Segmentation Insights
Heart Valves Market Type Outlook
Heart Valves Market Application Outlook
Heart Valves Market End Use Outlook
Heart Valves Market Material Outlook
Biological Tissue
Synthetic Polymer
Metallic Alloys
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2023 | 185.13(USD Million) |
| MARKET SIZE 2024 | 192.8(USD Million) |
| MARKET SIZE 2035 | 384.5(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.476% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Neovasc, St. Jude Medical, Edwards Lifesciences, Abbott Laboratories, Sino Medical Sciences Technology, AtriCure, Meril Life Sciences, Boston Scientific, Medtronic, Cardinal Health, LivaNova, JenaValve Technology, Terumo Corporation, Micro Interventional Devices, Surgical Innovations |
| SEGMENTS COVERED | Type, Application, End Use, Material |
| KEY MARKET OPPORTUNITIES | Aging population demand, Technological advancements in valves, Growth in minimally invasive procedures, Increasing prevalence of heart diseases, Rising investment in healthcare infrastructure |
| KEY MARKET DYNAMICS | Rising prevalence of cardiac diseases, Technological advancements in valve products, Increasing geriatric population, Growing demand for minimally invasive procedures, High healthcare expenditure and reimbursement policies |
| COUNTRIES COVERED | South Korea |
Frequently Asked Questions (FAQ) :
The South Korea Heart Valves Market is projected to be valued at 192.8 million USD in 2024.
By 2035, the South Korea Heart Valves Market is expected to reach a valuation of 384.5 million USD.
The CAGR for the South Korea Heart Valves Market is expected to be 6.476% during the period from 2025 to 2035.
In 2024, the Bioprosthetic Valves segment is expected to have the highest market value at 76.8 million USD.
The Mechanical Valves segment is projected to reach a market value of 96.0 million USD by 2035.
Key players in the South Korea Heart Valves Market include Neovasc, St. Jude Medical, Edwards Lifesciences, Abbott Laboratories, and Medtronic.
The Transcatheter Valves segment is expected to be valued at 68.0 million USD in 2024.
Significant growth opportunities in the market are driven by advancements in heart valve technology and increasing prevalence of heart diseases.
By 2035, the market for Bioprosthetic Valves is expected to grow to 153.6 million USD, reflecting strong demand.
The primary challenges include stringent regulations and the high cost of innovative heart valve products.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
